Skip to main content

Table 2 Top-ranked differentially methylated CpGs in T2E-fusion-positive versus T2E-fusion-negative prostate tumors

From: Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors

CpG ID

Chromosome

Gene

Location

CpG island

Mean β T2E-negative

Mean β T2E-positive

Mean β difference

Q-value

Hypermethylation

 cg11258089

5

PDE4D

Body; TSS200

Yes

0.20

0.53

0.33

1.19E−51

 cg22706610

5

PDE4D

Body; TSS200

Yes

0.22

0.50

0.28

1.19E−51

 cg26870744

5

PDE4D

Body; TSS200

Yes

0.17

0.43

0.27

1.19E−51

 cg07190535

5

PDE4D

Body; TSS1500

Yes

0.26

0.53

0.27

1.57E−50

 cg08554295

5

PDE4D

Body; TSS1500

No

0.18

0.46

0.29

1.57E−50

 cg16261871

5

PDE4D

Body; TSS200

Yes

0.25

0.52

0.28

2.83E−46

 cg19694010

12

IGR

Yes

0.19

0.45

0.27

3.45E−46

 cg15044248

17

SEPT9

TSS200; 5′ UTR; body

Yes

0.11

0.38

0.26

7.05E−46

 cg14087806

17

IGR

Yes

0.19

0.49

0.30

7.05E−46

 cg06848185

17

SEPT9

TSS1500; 5′ UTR; body

Yes

0.10

0.36

0.26

3.84E−45

 cg13468945

17

IGR

Yes

0.19

0.47

0.29

4.20E−43

 cg08378505

17

NT5C

Body

Yes

0.15

0.45

0.30

3.41E−40

 cg17300544

17

SEPT9

TSS200; 5′ UTR; body

Yes

0.18

0.47

0.29

7.49E−39

 cg26896572

3

C3orf14

TSS1500

Yes

0.26

0.53

0.27

2.28E−38

 cg21454031

17

IGR

No

0.22

0.48

0.26

5.03E−38

 cg10520594

17

NT5C

Body

Yes

0.19

0.44

0.25

9.43E−38

 cg15059608

3

C3orf14

TSS1500

No

0.32

0.58

0.25

3.36E−31

 cg21869055

19

KLK10

5′ UTR

Yes

0.26

0.51

0.25

3.06E−30

 cg25623934

2

TRIB2

Exon 1; body

Yes

0.22

0.49

0.27

1.53E−29

Hypomethylation

 cg08480458

3

CACNA1D

Body

Yes

0.47

0.15

0.32

5.42E−45

 cg15473186

3

CACNA1D

Body

Yes

0.57

0.31

0.27

1.28E−44

 cg06717750

16

RAB40C

Body

No

0.80

0.52

0.28

6.87E−43

 cg12668309

3

CACNA1D

Body

Yes

0.33

0.08

0.26

4.18E−42

 cg17312492

15

GREM1

5′ UTR

Yes

0.43

0.17

0.26

7.96E−42

 cg14337339

3

CACNA1D

Body

Yes

0.43

0.12

0.31

3.41E−40

  1. The table shows differentially methylated CpGs (FDR Q-value <0.00001) that have a mean methylation (β-value) difference of at least 25 % between fusion-positive versus fusion-negative PCa
  2. T2E TMPRSS2:ERG, TSS1500 200 to 1500 base pairs upstream of the transcription start site, TSS200 200 base pairs upstream of the transcription start site, UTR untranslated region, IGR intergenic region